Pharmaceutical

STAT+: Zyn scrutiny from Sen. Chuck Schumer prompts an ...

After Sen. Chuck Schumer raised concerns about Zyn nicotine pouches, conservativ...

Revolutionising healthcare: The role of digital twins

Using digital twins, healthcare professionals can analyse real-time individual h...

CAR-T therapies and cancer risk: No easy answers for th...

CAR-T cell therapies can provide durable cancer remission, however, a recent FDA...

Atossa Therapeutics progresses Phase II preventative br...

Atossa Therapeutics estimates a Q3 Phase II readout for Z-endoxifen, as it plans...

FDA expands approval of Dupixent for eosinophilic esoph...

Regeneron and Sanofi’s blockbuster anti-inflammatory drug generated global sales...

Travere signs $120m licensing deal with Renalys for spa...

Renalys plans to start a registrational trial for sparsentan as a treatment for ...

Drug shortages challenge type 2 diabetes patients in th...

Type-2 diabetes patients continue to be impacted by GLP-1 RA drug shortages in t...

STAT+: Democrats urge government to rein in Medicare Ad...

Sen. Elizabeth Warren wants the government to aggressively change how Medicare A...

STAT+: FTC sues to block a proposed hospital deal in No...

The government sued to block a proposed hospital deal in North Carolina, allegin...

STAT+: Generic group sues Illinois over a price-gouging...

The trade group for generic drug companies in the U.S. filed a lawsuit alleging ...

Merck CEO refused to testify in Senate because he’s not...

Merck's CEO told Sen. Bernie Sanders he wouldn't testify in the Senate because h...

Listen: The plight of the VC, Gilead’s latest setback, ...

This week on "The Readout LOUD": Are venture capitalists OK? Are bolt-ons good f...

Zyn scrutiny from Sen. Chuck Schumer prompts an unlikel...

After Sen. Chuck Schumer raised concerns about Zyn nicotine pouches, conservativ...

STAT+: CVS wants to become a medical powerhouse. Will l...

Even as CVS aims to expand, the economics underpinning its core retail business ...

Bernie Sanders’ showdown with pharma CEOs is coming to ...

STAT surveyed key lawmakers on whether they would support Sen. Bernie Sanders' p...

STAT+: Humana projects a tough road for Medicare Advant...

Humana’s Medicare Advantage business is faring even worse than the company let o...